Genetic testing firms such as Navigenics and 23andMe don't always agree when predicting an individual's risk for diseases based on the genetic makeup because they use different markers when making such predictions, genome pioneer J. Craig Venter and colleagues said in an opinion article in Nature. Companies could generate compatible genetic results by agreeing on a core set of markers, Venter said.

Full Story:

Related Summaries